A dual-track sale of Capiton-backed German omega-3 fatty acid manufacturer KD Pharma has been shelved, according to three sources familiar with the matter.
Technology investor plans to keep up the pace of its existing direct investments pace but expects to see more portfolio sellers
New business, Veld Capital, will raise new funds and also deploy via AnaCap's existing credit funds
Belgian GP expects ‘disruptive scaleup’ consumer investments to weather economic downturn
Equita and Houlihan Lokey hired for upcoming sale of Italian natural cosmetics group